Transforming Molecular Diagnostics

Rapid Detection of Infectious Diseases

Rapid and comprehensive detection of pathogens is an important strategy in reducing the spread of infectious disease. Our EasyScreen™ Detection Kits identify a larger number of pathogen targets in a shorter time frame than conventional methods.

Efficient Workflow

Traditional techniques for identifying viral, bacterial and protozoan pathogens require a high degree of knowledge and can take days to get a result. Our EasyScreen™ Detection Kits replace these methodologies with a single efficient workflow that requires less training, staff and hands-on-time, and gives a result in under 5 hours.

Automatable

The Genetic Signatures GS1 platform is a high-throughput bench top platform that performs both nucleic acid extraction and automated 384-well PCR set-up for the entire EasyScreen™ range. Our EasyScreen™ Detection Kits are also compatible with most existing automated nucleic acid extraction and real-time PCR instruments.

Standardised Sample Processing

Our EasyScreen™ Sample Processing Kits offer streamlined preparation of nucleic acids direct from the primary specimen. Our sample processing method is common for all specimen types leading to workflow efficiencies and standardised results between laboratories.

3base™ Multiplex Technology

Our 3base™ technology forms the basis of the EasyScreen™ Detection Kits. 3base™ allows for simpler design of molecular assays facilitating the simultaneous detection of multiple targets. 3base™ is compatible with both RNA and DNA targets.

Product Pipeline

Genetic Signatures has a number of new detection kits in development. All new products follow a defined development and commercialisation process comprised of (i) Experimental Analytical Validation, and (ii) Clinical and Regulatory Validation prior to release.

Genetic Signatures to Exhibit and Present at the annual Australian Society of Microbiology (ASM) meeting, 2-5 July, Hobart, Tasmania

| Latest News | No Comments

Genetic Signatures are proud to exhibit at the Australian Society for Microbiology Annual Scientific Meeting (ASM) 2017 in Hobart, Tasmania on 2-5 July 2017. Genetic Signatures has also been selected to…

Genetic Signatures Announces Regulatory Approval for Complete Enteric Product Suite in Australia and Europe and secures 3baseTM Patent in USA

| ASX Announcements, Latest News | No Comments

Genetic Signatures Announces Regulatory Approval for Complete Enteric Product Suite in Australia and Europe and secures 3baseTM Patent in USA Read the full article here

Genetic Signatures Exhibiting at ASM Microbe 2017 in New Orleans, Louisiana, United States, 1-5 June 2017.

| Latest News | No Comments

Genetic Signatures are pleased to be exhibiting at ASM Microbe 2017 in New Orleans, Louisiana, United States, 1-5 June 2017. The ASM Microbe conference showcases the best microbial sciences in…